Press release content from Business Wire. The AP news staff was not involved in its creation.
TransEnterix Announces New Training Center in EU
February 18, 2021 GMT
RESEARCH TRIANGLE PARK, N.C. (BUSINESS WIRE) Feb 18, 2021
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has agreed to partner with the Amsterdam Skills Centre (ASC) in the Netherlands for surgical training. This site will serve surgeons and staff throughout Europe with basic and advanced training on the Senhance® Surgical System. The ASC will also provide TransEnterix with a world-class facility to engage European surgeons in technology and clinical development studies.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Gilat Launches Next Generation VSAT Family Supporting 5G Networks and LEO/MEO Constellations
Gilat Satellite Networks Ltd.February 18, 2021 GMT
PETAH TIKVA, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today the launch of its next generation family of VSATs, Aquarius, supporting 5G networks and LEO/MEO constellations. The ultra-high-performance, multi-orbit VSATs provide over 2 Gigabits per second of concurrent speeds and support seamless satellite handover.
As 5G networks are deployed and customer demands continue to exponentially grow, Gilat’s Aquarius VSATs are designed to serve, with maximum efficiency, data and media intensive applications such as cellular 5G backhauling, maritime and enterprise. The VSATs exhibit ultra-high processing capabili
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference
Ascendis PharmaFebruary 18, 2021 GMT
COPENHAGEN, Denmark, Feb. 18, 2021 (GLOBE NEWSWIRE) Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced that the company will participate at the SVB Leerink 10th Annual Global Healthcare Conference. Company executives will provide a business overview and update on the company’s pipeline programs.
Details
Location
3:40 p.m. Eastern Time
Press release content from Accesswire. The AP news staff was not involved in its creation.
NBS Capital Inc. Completes Subscription Receipt Financing for Aggregate Proceeds of $5 Million
February 18, 2021 GMT
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWS WIRES
OTTAWA, ON / ACCESSWIRE / February 18, 2021 / NBS Capital Inc. (“NBS” or the “Company”) (TSXV:NBS.P) announces further to its press release of January 4, 2021, that in connection with its proposed scheme of arrangement (the “Arrangement”) with Electric Metals (USA) Limited (“EML”), EML and NBS have completed the non-brokered private placements (the “Financing”) of subscription receipts (the “Subscription Receipts”) in multiple tranches for aggregate gross proceeds of Cdn$5,049,635.13, at a price of Cdn$0.33 per Subscription Receipt. Pursuant to the fully subscribed Financing, EML issued a total of 13,308,407 Subscription Receipts for proceeds of Cdn$4,391,774.85, and NBS issued a tot
Press release content from PR Newswire. The AP news staff was not involved in its creation.
BAT accelerates its enterprise transformation towards A Better Tomorrow™
February 18, 2021 GMT
British American Tobacco Logo (PRNewsfoto/British American Tobacco)
LONDON, Feb. 18, 2021 /PRNewswire/ Speaking today at the Consumer Analyst Group of New York (CAGNY) Conference, BAT’s Chief Executive, Jack Bowles, shared his growth plans and ambitions for the next phase in the company’s transformation.
With strong New Category momentum and a clear pathway to their 2025 profitability, Bowles called 2021 a “pivotal year” for BAT, announcing an ambitious programme called QUEST to accelerate the company’s transformation to create the ‘Enterprise of the Future’.